Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Fast-growings companies in Carbonic anhydrase inhibitor
by Most Patent Filing In 3 Years in the world in 2022

The Carbonic anhydrase inhibitor top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 3 Years Carbonic anhydrase inhibitor Fast-growings in the world. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Carbonic anhydrase inhibitors are a class of pharmaceuticals that suppress the activity of carbonic anhydrase. Their clinical use has been established as anti-glaucoma agents, diuretics, antiepileptics, in the management of mountain sickness, gastric and duodenal ulcers, idiopathic intracranial hypertension, neurological disorders, or osteoporosis.
#
Company Name
Region
Tech Topics
Total
1
New Jersey, United States
Drug,Ophthalmic drugs,Health care,
...[+1]
Patent: 4
2
China
Patent: 2
3
Massachusetts, United States
Health care,Mitral valve surgery,Health equity,
...[+2]
Patent: 2
4
Jiangsu Sheng, China
Patent: 2
5
Heilongjiang Sheng, China
Patent: 1
6
Vilniaus apskritis, Lithuania
Patent: 1
7
HaMerkaz, Israel
Association (object-oriented programming),Intellectual property,Biotechnology,
...[+2]
Patent: 1
8
South Korea
Emergency department,Healthcare system,Medical tourism,
...[+2]
Patent: 1
9
Beijing Shi, China
Patent: 1
10
Indiana, United States
Financial asset,Technology transfer,Incubation,
...[+2]
Patent: 1
Page generation time: Apr 30 2025